With IPO Planned, Atossa Posts Revenues of $1,500 for FY 2011 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Atossa Genetics, which filed for an initial public offering in February, disclosed in a regulatory filing that it had $1,500 in revenues and a net loss of $3.4 million for full-year 2011.

Revenue figures compare to none from 2010. Atossa had a net loss of $1.1 million for FY 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.